
Developing effective NAFLD treatments faces challenges due to trial failures and limitations in trial design and measurement methods.


coremsg

Dr Vlad Ratziu, professor of hepatology at the Sorbonne Université, shares his thoughts on why treatments for fatty liver disease continue to fall short, in a conversation with Dr Nancy Reau.

Why Are NAFLD Treatments Failing in Clinical Trials?

challenges-in-developing-nafld-treatments


Challenges in Developing NAFLD Treatments
